SCHOLAR ROCK HOLDING CORP (SRRK) Stock News

What's going on in today's after hours session

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

Mentions: STZ XRTX GLYC TTOO ...

Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Mentions: MRNA ALNY EXEL CORT ...

Scholar Rock Highlights 2025 Strategic Priorities

Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress

Earnings Scheduled For November 12, 2024

Mentions: SILV SKYX XTNT HNRG ...

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

Scholar Rock to Participate in Upcoming Investor Conferences

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

Mentions: IBRX

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why Everybody's Talking About Scholar Rock Right Now

Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants